Commentary on Coyle et al., "The assessment of the economic return from controlled clinical trials"
- PMID: 15609191
- DOI: 10.1007/s10198-003-0191-4
Commentary on Coyle et al., "The assessment of the economic return from controlled clinical trials"
Comment on
-
The assessment of the economic return from controlled clinical trials. A framework applied to clinical trials of colorectal cancer follow-up.Eur J Health Econ. 2003;4(1):6-11. doi: 10.1007/s10198-002-0142-5. Eur J Health Econ. 2003. PMID: 15609163
Similar articles
-
Considering race/ethnicity and socio-economic status in randomized controlled trials. A commentary on Frampton et al.'s systematic review generalizing trial findings and tackling health disparities in asthma research.Soc Sci Med. 2009 Oct;69(8):1155-6. doi: 10.1016/j.socscimed.2009.06.019. Epub 2009 Jul 27. Soc Sci Med. 2009. PMID: 19640625 No abstract available.
-
Powerful spin in the conclusion of Wampold et al.'s re-analysis of placebo versus no-treatment trials despite similar results as in original review.J Clin Psychol. 2007 Apr;63(4):373-7. doi: 10.1002/jclp.20357. J Clin Psychol. 2007. PMID: 17279532
-
Lessons learned from independent central review.Eur J Cancer. 2009 Jan;45(2):268-74. doi: 10.1016/j.ejca.2008.10.031. Eur J Cancer. 2009. PMID: 19101138
-
Design and analysis issues for economic analysis alongside clinical trials.Med Care. 2009 Jul;47(7 Suppl 1):S14-20. doi: 10.1097/MLR.0b013e3181a31971. Med Care. 2009. PMID: 19536012 Review.
-
Outcomes in randomized controlled trials in psoriasis: what has changed over the last 20 years?J Dermatolog Treat. 2007;18(5):261-7. doi: 10.1080/09546630701487635. J Dermatolog Treat. 2007. PMID: 17917937 Review.